Kangstem Biotech Co Ltd

217730

Company Profile

  • Business description

    Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

  • Contact

    512 Teheran-ro, Gangnam-gu
    17th Floor, Sinan Building
    Seoul
    KOR

    T: +82 28881590

    http://www.kangstem.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    97

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,642.905.100.06%
CAC 407,779.728.38-0.11%
DAX 4023,933.23104.96-0.44%
Dow JONES (US)42,215.73117.030.28%
FTSE 1008,716.459.56-0.11%
HKSE23,224.40348.98-1.48%
NASDAQ19,175.8774.930.39%
Nikkei 22537,936.65496.33-1.29%
NZX 50 Index12,332.9451.630.42%
S&P 5005,912.1723.620.40%
S&P/ASX 2008,417.307.500.09%
SSE Composite Index3,353.0710.38-0.31%

Market Movers